274 related articles for article (PubMed ID: 26903548)
1. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
[TBL] [Abstract][Full Text] [Related]
2. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
[TBL] [Abstract][Full Text] [Related]
3. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.
Kuo CY; Long JD; Campo-Fernandez B; de Oliveira S; Cooper AR; Romero Z; Hoban MD; Joglekar AV; Lill GR; Kaufman ML; Fitz-Gibbon S; Wang X; Hollis RP; Kohn DB
Cell Rep; 2018 May; 23(9):2606-2616. PubMed ID: 29847792
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the CD40 ligand gene in a Chinese boy with X-linked hyper-IgM syndrome.
Liu PN; Li H; Li Q; Yin ZW; Zhou CY; Jiang MY; Guo X
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):270-4. PubMed ID: 25268346
[TBL] [Abstract][Full Text] [Related]
5. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.
Longo NS; Lugar PL; Yavuz S; Zhang W; Krijger PH; Russ DE; Jima DD; Dave SS; Grammer AC; Lipsky PE
Blood; 2009 Apr; 113(16):3706-15. PubMed ID: 19023113
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
7. X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.
Gallagher J; Adams J; Hintermeyer M; Torgerson TR; Lopez-Guisa J; Ochs HD; Szabo S; Salib M; Verbsky J; Routes J
J Clin Immunol; 2016 Aug; 36(6):564-70. PubMed ID: 27324886
[TBL] [Abstract][Full Text] [Related]
8. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.
Ramachandran R; Krishnan Y; Singh P; Kumar A; Mohanty A
Immunogenetics; 2023 Apr; 75(2):191-194. PubMed ID: 36478253
[TBL] [Abstract][Full Text] [Related]
9. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
[TBL] [Abstract][Full Text] [Related]
11. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
[TBL] [Abstract][Full Text] [Related]
12. CD40 Ligand Deficient C57BL/6 Mouse Is a Potential Surrogate Model of Human X-Linked Hyper IgM (X-HIGM) Syndrome for Characterizing Immune Responses against Pathogens.
Lopez-Saucedo C; Bernal-Reynaga R; Zayas-Jahuey J; Galindo-Gomez S; Shibayama M; Garcia-Galvez C; Estrada-Parra S; Estrada-Garcia T
Biomed Res Int; 2015; 2015():679850. PubMed ID: 26064940
[TBL] [Abstract][Full Text] [Related]
13. A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences.
Romero Z; Torres S; Cobo M; Muñoz P; Unciti JD; Martín F; Molina IJ
Gene Ther; 2011 Apr; 18(4):364-71. PubMed ID: 21107438
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
[TBL] [Abstract][Full Text] [Related]
15. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
[TBL] [Abstract][Full Text] [Related]
16. Female hyper IgM syndrome type 1 with a chromosomal translocation disrupting CD40LG.
Imai K; Shimadzu M; Kubota T; Morio T; Matsunaga T; Park YD; Yoshioka A; Nonoyama S
Biochim Biophys Acta; 2006 Mar; 1762(3):335-40. PubMed ID: 16311023
[TBL] [Abstract][Full Text] [Related]
17. Regulated expression of murine CD40L by a lentiviral vector transcriptionally targeted through its endogenous promoter.
Fernández-Rubio P; Torres-Rusillo S; Molina IJ
J Gene Med; 2015; 17(10-12):219-28. PubMed ID: 26223487
[TBL] [Abstract][Full Text] [Related]
18. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
[TBL] [Abstract][Full Text] [Related]
19. Diminished CD40L expression on T-cells in a case of disseminated cryptococcosis.
Mohanty SK; Thakral D; Gupta D; Kumar P; Mitra DK
Indian J Pathol Microbiol; 2018; 61(1):137-140. PubMed ID: 29567905
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA insert into CD40 ligand gene-associated X-linked hyper-IgM syndrome.
Li X; Xu D; Cheng B; Zhou Y; Chen Z; Wang Y
Mol Genet Genomic Med; 2021 May; 9(5):e1646. PubMed ID: 33764006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
